
FDA stalls decision on petition to suspend mRNA injections, citing ‘other priorities
Mary Anne Demasi PhD The US regulator quietly delays action on a petition calling for the suspension of mRNA injections—despite evidence of regulatory failure, DNA contamination, and a surge in cancers among young people. The U.S. Food and Drug Administration (FDA)